88. Chronic thromboembolic pulmonary hypertension
145 clinical trials,   112 drugs   (DrugBank: 22 drugs),   13 drug target genes,   52 drug target pathways

Searched query = "Chronic thromboembolic pulmonary hypertension", "CTEPH", "Idiopathic chronic pulmonary thromboembolism"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
2 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1EUCTR2008-006441-10-DE
(EUCTR)
27/05/201028/01/2010Double Blind Controlled Clinical Investigation into the Efficacy and Tolerability of subcutaneously administered Treprostinil Sodium in Patients with Severe (inoperable) Chronic Thromboembolic Pulmonary HypertensionDouble Blind Controlled Clinical Investigation into the Efficacy and Tolerability of subcutaneously administered Treprostinil Sodium in Patients with Severe (inoperable) Chronic Thromboembolic Pulmonary Hypertension Patients with Severe (inoperable) Chronic Thromboembolic Pulmonary HypertensionTrade Name: Remodulin 1mg/ml 20ml
Other descriptive name: TREPROSTINIL SODIUM
Trade Name: Remodulin 2.5mg/ml 20ml
Other descriptive name: TREPROSTINIL SODIUM
Trade Name: Remodulin 5mg/ml 20ml
Other descriptive name: TREPROSTINIL SODIUM
Trade Name: Remodulin 10mg/ml 20ml
Other descriptive name: TREPROSTINIL SODIUM
MRN-Medical Research Network GmbHNULLNot RecruitingFemale: yes
Male: yes
100Czech Republic;Germany;Austria
2EUCTR2008-006441-10-SK
(EUCTR)
31/08/200909/09/2009Double Blind Controlled Clinical Investigation into the Efficacy and Tolerability of subcutaneously administered Treprostinil Sodium in Patients with Severe (inoperable) Chronic Thromboembolic Pulmonary HypertensionDouble Blind Controlled Clinical Investigation into the Efficacy and Tolerability of subcutaneously administered Treprostinil Sodium in Patients with Severe (inoperable) Chronic Thromboembolic Pulmonary Hypertension Patients with Severe (inoperable) Chronic Thromboembolic Pulmonary HypertensionTrade Name: Remodulin (R)
Trade Name: Remodulin (R)
MRN-Medical Research Network GmbHNULLNot RecruitingFemale: yes
Male: yes
100Phase 3Czech Republic;Slovakia;Austria;Germany